Pasithea Therapeutics Corp. (KTTA) stock
KTTANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.43−0.07 (-13.14%)
Close on Nov 17, 2026Market cap $14.51MP/E –Yield –
Pasithea Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Pasithea Therapeutics's operating margin for the twelve months ending Dec 31, 2022 was -2587.3%. For fiscal 2022 it was -2587.3%, against -29925.7% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -2587.3% | +27338.4 |
| FY2021 | Dec 31, 2021 | -29925.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | -1679.5% | – |
| Q3 FY2022 | Sep 30, 2022 | -1763.8% | – |
| Q2 FY2022 | Jun 30, 2022 | -19229.5% | – |
| Q1 FY2022 | Mar 31, 2022 | -15221.0% | – |
See a number that looks wrong?